Skip to content

Clinical Research Protocol for Observational Study on the Effects of Gaokangtai Gummy Candy on Human Blood Pressure

Clinical Research Protocol for Observational Study on the Effects of Gaokangtai Gummy Candy on Human Blood Pressure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111792
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal high blood pressure

Interventions

Group:Adults take 2 capsules each time, once in the morning and once in the evening. Swallow them after meals (better effect 30 minutes before meals). Take continuously for 30 days.
Placebo:Adults take 2 capsules each time, once in the morning and once in the evening. Swallow them after meals (better effect 30 minutes before meals). Take continuously for 30 days.

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age: 18 - 65 years old (inclusive of boundary values), gender not restricted; (2) Normal high blood pressure group: Individuals whose blood pressure is within the slightly elevated range of the normal range (normal high blood pressure), with systolic blood pressure ranging from 120 to 139 mmHg and/or diastolic blood pressure ranging from 80 to 89 mmHg, meeting any one of these conditions is sufficient; (3) Willing to follow the doctor's intervention plan and cooperate with follow-up, provide informed consent and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with serious diseases such as heart, liver, kidney and hematopoietic system disorders, as well as patients with mental illnesses; (2) Those who have taken items related to the tested functions within a short period of time, which may affect the judgment of the results; (3) Those who did not consume the tested samples as per the regulations, or whose data is incomplete, which may affect the judgment of efficacy or safety; (4) Those who are allergic or intolerant to the ingredients of the research products; (5) Pregnant, planning to become pregnant or lactating women; (6) Those who have participated in or are currently participating in other clinical studies within the last 1 month; (7) Those who, in the researcher's judgment, are not suitable to participate in this study or are prone to drop out.

Design outcomes

Primary

MeasureTime frame
Diastolic blood pressure and systolic blood pressure;Observe the main symptoms: headache, dizziness, palpitations, tinnitus, insomnia, irritability, soreness and weakness in the waist and knees, etc.;

Secondary

MeasureTime frame
Vital signs;

Countries

China

Contacts

Public ContactZhou huan

The First Affiliated Hospital of Anhui Medical University

zhouhuanbest@vip.163.com+86 136 6552 7160

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026